OACCU — Oaktree Acquisition Corp. III Life Sciences

—
Nasdaq · Financials · Diversified Financial Services · CIK 2029769 ·
Last close
$10.75
Market Cap
—
52W High
$12.47
52W Low
$10.65
ADV30
183
Next earnings
—
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -2,381,193 -452,553 208,206,263 1,225,603 10,866,699
Jun 2026 0 — -261,958 1,604,621 206,540,698 1,179,670 8,748,581
Mar 2026 0 — -456,538 1,394,121 204,830,388 1,276,930 8,642,892
Dec 2025 0 — -255,496 1,788,948 203,111,772 1,434,965 8,318,397

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-455,689
Investing CF
$250,000
Financing CF
—
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-7,489,191
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-1,199,571
Pretax Income TTM
$6,754,432
Interest Exp TTM
—
Analysts
—

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -1,195,687 7,288,824 203,111,772 8,318,397 194,793,375 -422,079
Dec 2024 — — — 195,250,622 7,746,071 187,504,551 —

TTM Snapshot

Revenues TTM
$7,954,003
NetIncome TTM
$6,754,432
OpCashFlow TTM
—
Assets (Latest)
$206,540,698
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
HASI HA Sustainable Infrastructure Capital, Inc. $4.86B $38.01 —
DMII Drugs Made In America Acquisition II Corp. $652.61M $10.24 —
EVAC EQV Ventures Acquisition Corp. II $486.85M $10.37 —
BCSS Bain Capital GSS Investment Corp. $480.73M $10.25 —
CEPF Cantor Equity Partners IV, Inc. $473.69M $10.32 —

Recent Insider Activity

No insider activity indexed for this ticker.